Search results for "Clinical Study"

showing 10 items of 211 documents

Impact of dual antiplatelet therapy with proton pump inhibitors on the outcome of patients with acute coronary syndrome undergoing drug-eluting stent…

2012

This study aimed to assess if proton pump inhibitors (PPIs) may reduce the effectiveness of clopidogrel, than H2 antagonist (anti-H2) in order to determine rehospitalization for acute coronary syndrome (re-ACS), target vessel revascularization (TVR) and cardiac death. This case-control study included 176 patients with ACS undergoing angioplasty (PCI) with drug-eluting stent implantation. The population was divided into two groups: PPI group (n=121) consisting of patients receiving at discharge dual antiplatelet therapy (DAT) plus PPI and anti-H2 group (n=55), consisting of patients receiving at discharge DAT + H2 receptor antagonist (H2RA). In a followup of 36 months the prevalence of ACS e…

Acute coronary syndromemedicine.medical_specialtyeducation.field_of_studyArticle Subjectbusiness.industrymedicine.medical_treatmentPopulationmedicine.diseaseClopidogrelEsomeprazoleSurgeryantiplatelet therapy PPIs clopidogrel anti-H2 ACS PCIDrug-eluting stentInternal medicineAngioplastyConventional PCImedicineCardiologyClinical StudyeducationbusinessOmeprazolemedicine.drug
researchProduct

Effect of neuromuscular electrical stimulation frequency on postprandial glycemia, current-related discomfort, and muscle soreness. A crossover study

2019

Consensus is lacking regarding optimal neuromuscular electrical stimulation (NMES) parameters for postprandial glycemic control. Therefore, the aim of this study was to determine the NMES frequency inducing the greatest hypoglycemic effect in healthy individuals. The secondary aim was to compare current-related discomfort and muscle soreness between different frequencies. We conducted an experimental clinical study with a randomized crossover design. Sixteen healthy and sedentary participants received NMES for 20 min at 5, 10, or 50 Hz (pulse duration: 400 μs, on-off ratio: 4:12 s) following a standardized meal. Glycemia, discomfort, and muscle soreness during and after NMES were compared …

AdultBlood GlucoseMale030506 rehabilitationTime FactorsPhysiologyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismStimulationClinical studyYoung Adult03 medical and health sciences0302 clinical medicinePhysiology (medical)HumansMedicineMuscle StrengthMuscle SkeletalGlycemicMealCross-Over StudiesNutrition and Dieteticsbusiness.industryMyalgiaGeneral MedicinePostprandial PeriodCrossover studyElectric StimulationPostprandialPatient toleranceHealthy individualsAnesthesiaMuscle FatigueFemale0305 other medical sciencebusinessApplied Physiology, Nutrition, and Metabolism
researchProduct

Gallstone dissolution with chenodeoxycholic acid. A clinical study.

1980

Out of 95 patients with radiolucent gallstones who enrolled in a clinical study with chenodeoxycholic acid (CDC) for gallstone dissolution 75 patients with cholecystolithiasis completed 12 months of treatment. As a side effect 31% of patients reported intermittent diarrhea which did not cause cessation of therapy or missing of work. The incidence of biliary colic was markedly decreased during treatment in comparison to the rate in the year before. From more than 20 laboratory values checked before start and every 3 months during therapy only aminotransferases increased up to 3 fold in 20% of patients. gamma-GT elevated in 31% of patients before treatment improved in half of these patients d…

AdultDiarrheaMalemedicine.medical_specialtyAdolescentBiliary colicBody weightChenodeoxycholic AcidGastroenterologyClinical studyGallstone dissolutionchemistry.chemical_compoundCholelithiasisChenodeoxycholic acidInternal medicineDrug DiscoverymedicineHumansIn patientGenetics (clinical)AgedDiminutionDose-Response Relationship Drugbusiness.industryBody WeightGeneral MedicineGallstonesMiddle Agedmedicine.diseasechemistrySolubilityMolecular MedicineFemalemedicine.symptombusinessConstipationKlinische Wochenschrift
researchProduct

Fungiform papillae density in patients with burning mouth syndrome and xerostomia

2011

Objective: The aim of this study was to analyze fungiform papillae density in patients with burning mouth syndrome (BMS) and xerostomia. Study design: In this cross-sectional clinical study, sixty patients were included (20 with BMS, 20 with xerostomia and 20 healthy controls). The fungiform papillae density was analyzed over a small region on the anterior tip of the tongue with the aid of a digital camera. The number of papillae was measured in an area of 19 mm2. Results: The patients with BMS showed significantly higher fungiform papillae density than the patients with xerostomia; though no statistically significant differences were recorded versus the control group. In the BMS group, 65%…

AdultMaleDentistryBurning Mouth SyndromeXerostomiaClinical studystomatognathic systemTongueHumansMedicineIn patientProspective StudiesLingual papillaGeneral DentistryAgedAged 80 and overOral Medicine and Pathologyintegumentary systemurogenital systembusiness.industryMiddle AgedBurning mouth syndrome:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesCross-Sectional Studiesmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASFemaleResearch-ArticleSurgerymedicine.symptombusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Effect of implant macro-design on primary stability: A prospective clinical study

2016

Background Implant restorations have become a high predictable treatment option. Several caracteristics such as surgical technique and implant design can influence the treatment outcomes. The aim of the present study was to evaluate the influence of implant macro-design on primary stability measured with resonance frequency analysis (RFA) and insertion torque (IT). Material and Methods A total of 47 implants divided in two groups: Test group (TI): 22 Tapered MIS® Seven implants; Control group (CI): 25 cylindrical Astra® Osseospeed implants. All implants were inserted following the manufacturers’ standard protocols. Implant primary stability was measured at the moment of implant placement by…

AdultMaleInsertion torquemedicine.medical_specialtyTreatment outcomeDentistryOdontología02 engineering and technologyDental Prosthesis Retention03 medical and health sciences0302 clinical medicineDental Prosthesis DesignmedicineHumansProspective StudiesGeneral DentistryDental Implantsbusiness.industryResearchImplant design030206 dentistry:CIENCIAS MÉDICAS [UNESCO]021001 nanoscience & nanotechnologyDenture RetentionCiencias de la saludSurgeryResonance frequency analysisDental Prosthesis DesignOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASProspective clinical studyFemaleSurgeryImplantOral Surgery0210 nano-technologybusinessDental Prosthesis RetentionMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

What are the risk factors for postoperative infections of third molar extraction surgery: A retrospective clinical study-?

2018

Background This study aimed to identify (1) the predilection site of postoperative infection after third molar extraction surgery, (2) risk factors associated with postoperative infection, and (3) the cause of the difference between delayed- and early-onset infections. Material and Methods This retrospective study included 1010 patients (396 male, 614 female) who had ≥1 third molars extracted (2407; 812 maxilla, 1595 mandible). The risk factors were classified as attributes, general health, anatomic, and operative. Outcome variables were delayed- and early-onset infections. Results Postoperative infection was completely absent in the maxilla, and all infections occurred in the mandible, wit…

AdultMaleMolarmedicine.medical_specialtyRetrospective dataClinical study03 medical and health sciencesPostoperative Complications0302 clinical medicinestomatognathic systemRisk FactorsPostoperative infectionmedicineHumansMandibular DiseasesGeneral DentistryRetrospective Studiesbusiness.industryResearchMandibleRetrospective cohort studyBacterial Infections030206 dentistry:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngology030220 oncology & carcinogenesisMaxillaTooth ExtractionUNESCO::CIENCIAS MÉDICASFemaleMolar ThirdSurgeryGeneral healthOral SurgerybusinessThird molar extraction surgery; delayed-onset infection; early-onset infection; postoperative infectionMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Prevalence of Occult Hepatitis B Virus Infection in a Cohort of HIV-Positive Patients Resident in Sicily, Italy

2013

Occult hepatitis B virus (OBI) in HIV-infected groups is still debated, as well as the associated risk-factors and clinical significance. In this paper, we examined a total of 405 HBsAg-negative/HIV-infected patients enrolled from January 2007 to December 2009. Overall, the prevalence of OBI was 5.9% (95% confidence interval (CI95%): 3.8–8.7%); it was more frequently associated with “anti-HBc alone” serological marker (11.3%; adjusted odds ratio = 3.7, CI95%: 1.4–9.8), although it was also detected in the absence of any HBV serological marker (4.9%; CI95%: 2.3–9.1%). A low prevalence of anti-HCV-positive patients with OBI was found (3.1%; CI95%: 0.6–8.7%). HIV RNA plasma levels or other imm…

AdultMaleOccult HBV HIV Prevalence Sicily Italymedicine.medical_specialtyHepatitis B virusArticle Subjectlcsh:MedicineHIV Infectionsmedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataGeneral Biochemistry Genetics and Molecular BiologySerologyInternal medicineGenotypemedicinePrevalenceHumansClinical significanceSicilyDemographyHepatitis B virusHepatitis B Surface AntigensGeneral Immunology and Microbiologybusiness.industrylcsh:Rvirus diseasesGeneral MedicineOdds ratioHepatitis Bmedicine.diseaseHepatitis BOccultdigestive system diseasesCohortImmunologyClinical StudyFemalebusiness
researchProduct

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

2012

Background: New therapeutic options for metastatic pancreatic cancer are urgently needed. In pancreatic cancer, overexpression of the epidermal growth factor receptor 2 (HER2) has been reported in up to 45%. This multicentre phase II study investigated the efficacy and toxicity of the HER2 antibody trastuzumab combined with capecitabine in the patients with pancreatic cancer and HER2 overexpression. Methods: Primary endpoint was progression-free survival (PFS) after 12 weeks. A total of 212 patients were screened for HER2 expression. Results: Immunohistochemical (IHC) HER2 expression was: 83 (40%) grade 0, 71 (34%) grade 1, 31 (15%) grade 2, 22 (11%) grade 3. A total of 17 patients with IHC…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyReceptor ErbB-2medicine.medical_treatmentpancreatic cancerGene ExpressionPhases of clinical researchKaplan-Meier EstimateAdenocarcinomaAntibodies Monoclonal HumanizedchemotherapyDeoxycytidineDisease-Free SurvivalCapecitabineTrastuzumabInternal medicinePancreatic cancerAntineoplastic Combined Chemotherapy Protocolsgrowth factorsmedicineHumansskin and connective tissue diseasesneoplasmsCapecitabineAgedChemotherapybusiness.industryCancerMiddle AgedTrastuzumabmedicine.diseasePancreatic NeoplasmsTreatment OutcomeOncologyFluorouracilimmunohistochemistryClinical StudyAdenocarcinomaFemaleFluorouracilbusinessmedicine.drugBritish Journal of Cancer
researchProduct

Validity of a questionnaire developed to measure the impact of a high‐fidelity simulation intervention: A feasibility study

2019

To evaluate the validity and responsiveness of a questionnaire developed to measure the impact of a high-fidelity simulation intervention.A pre- and postintervention design.In August 2017, 107 participants completed a questionnaire measuring knowledge and perceived self-confidence pre- and postintervention. Validity of the questionnaire was determined by expert reviews, individual interviews and estimates of the changes in knowledge and perceived self-confidence. The changes were estimated by the differences between paired proportions of participants. The responsiveness of the ordered categorical item scores on self-confidence was evaluated by the measure of systematic group change and indi…

AdultMaleOrdinal datamedia_common.quotation_subjectFidelitylaw.inventionYoung Adult03 medical and health sciences0302 clinical medicineRandomized controlled triallawSurveys and QuestionnairesIntervention (counseling)Humans030212 general & internal medicineNurse educationCategorical variableGeneral Nursingmedia_commonModels Statistical030504 nursingClinical study designReproducibility of ResultsMiddle AgedScale (social sciences)Feasibility StudiesFemale0305 other medical sciencePsychologyClinical psychologyJournal of Advanced Nursing
researchProduct

Bovine pericardium based non-cross linked collagen matrix for successful root coverage, a clinical study in human

2012

Abstract Introduction The aim of this study was to clinically assess the capacity of a novel bovine pericardium based, non-cross linked collagen matrix in root coverage. Methods 62 gingival recessions of Miller class I or II were treated. The matrix was adapted underneath a coronal repositioned split thickness flap. Clinical values were assessed at baseline and after six months. Results The mean recession in each patient was 2.2 mm at baseline. 6 Months after surgery 86.7% of the exposed root surfaces were covered. On average 0,3 mm of recession remained. The clinical attachment level changed from 3.5 ± 1.3 mm to 1,8 ( ± 0,7) mm during the observational time period. No statistically signifi…

AdultMalePathologymedicine.medical_specialtylcsh:Specialties of internal medicineBovine pericardiumClinical NeurologyConnective tissueMatrix (biology)Gingival recessionClinical studylcsh:RC581-951medicineAnimalsHumansroot coverageddc:610Tooth RootGeneral Dentistryconnective tissueTissue Scaffoldsbusiness.industryDentistry(all)Researchguided tissue regenerationAnatomycollagen matrixMiddle Agedbovine pericardiumRoot coveragemedicine.anatomical_structureOtorhinolaryngologycardiovascular systemHead and neck surgeryGuided Tissue Regeneration PeriodontalCattleFemaleNeurology (clinical)CollagenbusinessPericardiumHead & Face Medicine
researchProduct